# A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Ca

Source: https://onco.cc/trials/nct05969171/  
OnCo record `nct05969171` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of gemcitabine + nab-paclitaxel in pancreatic cancer, run by Fudan University, now recruiting.

## Summary

A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT05969171 by Fudan University, with a registry enrolment figure of 65 participants, started 2023-12-05 and due to reach its primary completion in 2026-12-31. Interventions recorded: Surufatinib, gemcitabine, nab-paclitaxel; Nab-paclitaxel, gemcitabine. Conditions listed: Pancreatic Cancer Metastatic. Primary outcome: Progression-free survival. Pancreatic eligibility wording from the registry: "Unresectable, locally advanced or metastatic pancreatic cancer confirmed by histopathology or cytology;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT05969171
- Phase: 2
- Setting: A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With Gemcitabine and Nab-paclitaxel or Gemcitabine Combined With Nab-paclitaxel in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
- Sponsor: Fudan University
- Enrolled: 65

## Sources

- ClinicalTrials.gov NCT05969171: https://clinicaltrials.gov/study/NCT05969171

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Gemcitabine + nab-paclitaxel](https://onco.cc/drugs/gemcitabine-nab-paclitaxel/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05969171.json